National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-FLT-1 ribozyme
A nuclease-stabilized synthetic ribozyme with potential antineoplastic activity. Anti-Flt-1 ribozyme cleaves the mRNA encoding vascular endothelial growth factor 1 (VEGF-1, or Flt-1), thereby specifically inhibiting VEGF-stimulated angiogenesis, tumor growth, and metastasis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Angiozyme
Foreign brand name:Angiozyme
Code name:RPI.4610



Previous:anti-denatured collagen recombinant monoclonal antibody TRC093, anti-EGFRvIII vaccine CDX-110, anti-endoglin monoclonal antibody TRC105, anti-EpCAM antibody fragment -Pseudomonas exotoxin fusion protein, anti-EpCAM antibody fragment-bouganin fusion protein
Next:anti-GP-3 monoclonal antibody, anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968, anti-human chorionic gonadotropin vaccine, anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov